Loading...

Digital Infrastructure And Specialty Services Will Redefine Healthcare Delivery

Published
06 Aug 24
Updated
04 Sep 25
AnalystConsensusTarget's Fair Value
US$333.29
7.6% undervalued intrinsic discount
10 Sep
US$308.07
Loading
1Y
36.9%
7D
6.7%

Author's Valuation

US$333.297.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on04 Sep 25

With both Cencora’s net profit margin and consensus revenue growth forecasts holding steady, analysts have maintained their price target unchanged at $333.29. What's in the News Cencora completed the repurchase of 4,895,419 shares (2.49% of shares outstanding) for $1,118.1 million under its buyback program announced in May 2024; no shares were repurchased from April to June 2025.

Shared on07 May 25
Fair value Increased 9.57%

Shared on30 Apr 25
Fair value Increased 0.84%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Increased 0.80%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Increased 3.73%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 0.38%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 2.88%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 0.55%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Decreased 14%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.